Cytoreductive Gastrectomy

1

Review clinical trials related to Cytoreductive Gastrectomy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer

The results of the current studies to determine the optimal strategy for metastatic gastric cancer remain contrversial worldwide. Hypothesis: Cytoreductive Gastrectomy After Systemic Therapy will improve survival time for metastasis gastric cancer compared to Systemic Therapy alone.

Participants needed: 250
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: University Medical Center Ho Chi Minh City (UMC)Updated: Aug 27, 2025Locations: 1
Eligibility criteria

Age 18-75 [+18]

Any extra-abdominal metastasis at diagnosis or during systemic treatment. [+20]